?? ????? |
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)- |
?????? |
2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI); ?????????[7,8]??????[2,3-c]pyrazol-1-ol,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-(6CI,7CI); 17-????-5a-androstano[3,2-c]pyrazol-17b-ol; 17-????-????????[4',3':2,3]-5a-????????-17b-ol; 17a-????-17b-hydroxy-5a-androstano(3,2-c)pyrazole; 17b-????????-17-????-5a-?????????[3,2-c]pyrazole; 17b-????????-17a-????-5a-?????????[3,2-c]pyrazole; ??????; ????????????; ????????????; Androstanazolestanazol; ??????; NSC233046; ????????; ????????; ?????????; ???????; ??????????; ???????; ?????? 14833; ??????????; ????????; ???????? ????; ???????? V |
?? ????? |
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-;2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-(6CI,7CI); 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol; 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol; 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole; 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole; 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC233046; Stanabolic; Stanazolol; Stanozolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V |
????????? ??????? |
C21H32N2O |
???? ???????? |
328.55 |
???? CAS |
302-96-5 |
???? ???????? |
|
?????? |
1.129g/cm3 |
????? ????? |
490.8°Cat760mmHg |
????? ???? |
250.7°C |
Hazard ?????? |
|
??????? ???? |
|
?????? ????? |
x." target="_blank">Human systemic effects by ingestion: jaundice. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.:;
|
|